AbbVie
ABBV
#30
Rank
$266.85 B
Marketcap
$151.01
Share price
-0.47%
Change (1 day)
28.95%
Change (1 year)

The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โ€œABBVโ€.

Market capitalization of AbbVie (ABBV)

Market cap: $266.85 Billion

As of May 2022 AbbVie has a market cap of $266.85 Billion. This makes AbbVie the world's 30th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to mesure how much a company is worth.

Market cap history of AbbVie from 2012 to 2022

Year Market cap Change
2022$266.85 B11.48%
2021$239.37 B26.54%
2020$189.17 B44.47%
2019$130.94 B-3.95%
2018$136.33 B-11.7%
2017$154.39 B51.71%
2016$101.76 B6.7%
2015$95.37 B-8.42%
2014$104.14 B24.23%
2013$83.82 B55.32%
2012$53.97 B

End of Day market cap according to different sources

On May 20th, 2022 the market cap of AbbVie was reported to be:

$266.85 Billion
by Yahoo Finance
$266.85 Billion
by CompaniesMarketCap
$266.85 Billion
by Nasdaq
$266.85 Billion
by Iex Cloud

Market capitalization for similar companies or competitors

Name Market cap Market cap differencediff. Country
$294.40 B 10.33%๐Ÿ‡บ๐Ÿ‡ธ USA
$283.95 B 6.41%๐Ÿ‡บ๐Ÿ‡ธ USA
$132.21 B-50.45%๐Ÿ‡บ๐Ÿ‡ธ USA
$29.23 B-89.04%๐Ÿ‡บ๐Ÿ‡ธ USA
$80.07 B-69.99%๐Ÿ‡บ๐Ÿ‡ธ USA
$162.21 B-39.21%๐Ÿ‡บ๐Ÿ‡ธ USA
$205.18 B-23.11%๐Ÿ‡ฌ๐Ÿ‡ง UK
$114.83 B-56.97%๐Ÿ‡ฌ๐Ÿ‡ง UK
$8.23 B-96.91%๐Ÿ‡บ๐Ÿ‡ธ USA